Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The best treatment depends on your specific concerns
Wegovy is administered once weekly via subcutaneous injection, and patients have flexibility regarding the day and time of administration
This information is for educational purposes only and is not a substitute for professional medical advice
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation
Month 4 Patients experienced a significant improvement in HbA1c level (reduction of 1.2%) from the baseline (8.28%), and fasting blood glucose level decreased further to 6.4 mmol/L from the baseline (9.6 mmol/L)
the net payment could be discounted by as much as 79%
US$ 27.32
US$ 27.86
US$ 27.14
